Sigma-Tau公司宣佈兒童VSL#3益生菌登陸美國

    October 16, 2012 —Sigma-Tau Pharmaceuticals, Inc., announced today the U.S. launch of VSL#3® JUNIOR, a once-a-day, high-potency probiotic medical food for the dietary management of children who suffer from irritable bowel syndrome (IBS) and ulcerative colitis (UC). Unlike other marketed probiotics, VSL#3® JUNIOR is presently the only probiotic sold as a medical food for IBS and UC. Refrigerated VSL#3® JUNIOR contains 8 proprietary strains of 225 billion live bacteria, making it approximately 50 times more potent than the average probiotic.
    2012年10月16日，Sigma-Tau公司宣佈兒童VSL#3益生菌登陸美國。該產品是用於患有腸易激綜合徵、潰瘍性結腸炎兒童的膳食管理的保健食品。與其他益生菌不同，VSL#3益生菌是目前唯一一個作為治療腸易激綜合徵和潰瘍性結腸炎的保健食品。凍乾的VSL#3益生菌含有8大類2250億株活菌，效果是普通益生菌的50倍。（信息來源：Sigma-Tau公司官網）